BETHANY FIELD: Open Payments
NPI 1013635317 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$251 in 14 payments from 10 companies in 2025. Trend: 2023 $310 · 2024 $304 · 2025 $251
Food & beverage: $251
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $45 |
| Exact Sciences Corporation | 2 | $40 |
| Lilly USA, LLC | 2 | $38 |
| Novo Nordisk Inc | 1 | $25 |
| SHIELD THERAPEUTICS INC | 1 | $22 |
| ABBVIE INC. | 1 | $17 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
| Currax Pharmaceuticals LLC | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $16 |
| Amgen Inc. | 1 | $15 |
Products named: AIRSUPRA, Cologuard Collection Kit, MOUNJARO, Wegovy, ACCRUFER, QULIPTA, GEMTESA, CONTRAVE.
Industry payments across PA — which companies pay providers there.
